" /> mTORC1/mTORC2 Inhibitor XL388 - CISMeF





Preferred Label : mTORC1/mTORC2 Inhibitor XL388;

NCIt synonyms : mTOR Inhibitor XL388; TORC1/TORC2 Inhibitor XL388;

NCIt related terms : XL-388;

NCIt definition : An orally bioavailable, ATP-competitive inhibitor of raptor-mammalian target of rapamycin (mTOR) complex 1 (mTOR complex 1; mTORC1; TOR complex 1; TORC1) and rictor-mTOR (mTOR complex 2; mTORC2; TOR complex 2; TORC2), with potential antineoplastic activity. Upon oral administration, mTORC1/mTORC2 inhibitor XL388 targets, selectively binds to and inhibits both mTORC1 and mTORC2, which may result in apoptosis and a decrease in proliferation in mTORC1/2-expressing tumor cells. mTOR is a serine/threonine kinase that is upregulated in some tumors; it plays an important role in the PI3K/Akt/mTOR signaling pathway which is often deregulated in cancer cells.;

UNII : B7I5G3Z7XR;

CAS number : 1251156-08-7;

Molecule name : XL 388; XL-388;

NCI Metathesaurus CUI : CL1927578;

Détails


Vous pouvez consulter :


Nous contacter.
31/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.